These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [the oral use of a progestational hormone (Provera 100) as an adjuvant in therapy of adenocarcinoma of the kidney. Preliminary report]. Liberti M; Di Silverio F; Concolino G; Tenaglia R; Marocchi A Minerva Urol; 1980; 32(3):175-8. PubMed ID: 7432332 [TBL] [Abstract][Full Text] [Related]
7. Current status of chemotherapy, hormonal therapy, and immunotherapy in the treatment of renal cell carcinoma. Poster DS; Bruno S; Penta JS; Pinna K; Vilk P; Macdonald JS Am J Clin Oncol; 1982 Feb; 5(1):53-60. PubMed ID: 7081138 [TBL] [Abstract][Full Text] [Related]
15. Renal cell carcinoma: analysis of 31 cases with assessment of endocrine therapy. Papac RJ; Ross SA; Levy A Am J Med Sci; 1977; 274(3):281-90. PubMed ID: 610416 [TBL] [Abstract][Full Text] [Related]
16. Chemotherapy and endocrine therapy in metastatic disease. Pritchard KI Curr Opin Oncol; 1989 Dec; 1(2):324-32. PubMed ID: 2489975 [No Abstract] [Full Text] [Related]
17. [Hormone therapy of metastasizing breast carcinoma]. Hagen MF; Thürlimann B Ther Umsch; 1996 Nov; 53(11):820-8. PubMed ID: 8984687 [TBL] [Abstract][Full Text] [Related]
19. Cancer of the breast. Endocrine and hormonal therapy. Kardinal CG; Donegan WL Major Probl Clin Surg; 1979; 5():361-404. PubMed ID: 379452 [TBL] [Abstract][Full Text] [Related]